Institution identification

Institution ID

3331239

Institution full name and acronym

University of Southern Denmark (SDU)

Institution countries

Denmark

Type of institution

Educational Institution

Institution role

Researcher

Institution website

ENCePP partner

No
Institution description
Publicly funded university
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

Drug-drug interactions between dicloxacillin/flucloxacillin and DOACs
Long-term real-world safety of ozanimod – A post-authorisation safety study (PASS) in patients diagnosed with ulcerative colitis
Multinational Observational Database Study on Imminent Osteoporotic Fracture Risk: Stage 1 (IFRISK)
NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry data
Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries
The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases
The prognosis of coronavirus disease (COVID-19) in patients recently treated with immunosuppressant medications.
Use of Low-dose Quetiapine and the Risk of Major Adverse Cardiovascular Events
Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study (NSAID COVID-19)